PFM Health Sciences’s Corpay CPAY Stock Holding History

PFM Health Sciences’s Portfolio CPAY Stock Details CPAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-285,124	Closed	-$42.4M	–	104
2014 Q4	$42.4M	Sell	285,124 -191,916	-40%	-$27.7M	0.99%	34
2014 Q3	$67.8M	Buy	+477,040	New	+$65.7M	1.56%	26

Other funds holding CPAY

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Valinor Management New York $32.2M AUM 44.16% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

PFM Health Sciences's CPAY Position: Q1 2015 in Review

PFM Health Sciences sold out of Corpay (CPAY) in Q1 2015, closing a stake of 285,124 shares — an estimated $42.4M sold.

PFM Health Sciences first reported a position in CPAY in Q3 2014 and held it in 2 quarters. The position peaked at $67.8M in Q3 2014. 325 funds tracked by Wall St. Rank hold CPAY as of Q1 2015.

PFM Health Sciences reported no remaining Corpay position as of Q1 2015 after selling out during the quarter.
PFM Health Sciences sold 285,124 Corpay shares in Q1 2015, an estimated $42.4M.
PFM Health Sciences first reported a position in Corpay in Q3 2014 and held it in 2 quarters.
PFM Health Sciences's Corpay position peaked at $67.8M in Q3 2014.
325 funds tracked by Wall St. Rank held Corpay as of Q1 2015.

Based on PFM Health Sciences's 13F filing for Q1 2015, filed 15 May 2015.